The US Food and Drug Administration (FDA) recently released several new draft guidances concerning topical generic drug products submitted under abbreviated new drug applications (ANDAs). The agency’s ...
FDA finalizes guidance on assessing bioequivalence of topical drugs The US Food and Drug Administration (FDA) has finalized guidance for manufacturers on using physicochemical and structural (Q3) ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results